Literature DB >> 19468698

[Ornithine transcarbamylase deficiency in adolescence and adulthood: first manifestation with life-threatening decompensation].

M Bürle1, H Mende, U Plum, M Bluthardt, M Walka, G Geldner.   

Abstract

BACKGROUND: Ornithine transcarbamylase (OTC) deficiency is the most frequent innate disorder of the urea cycle and is X-chromosome linked. The disease normally manifests itself shortly after birth and is fatal when untreated. Due to the different expression and X-chromosomal inheritance the manifestation of symptoms can appear later particularly in girls and young women. The first symptoms are non-specific signs of elevated cerebral pressure as a result of a hyperammonemia, which range from nausea and headache up to cerebral herniation with fatal outcome. Measurement of plasma ammonia levels is a simple yet important screening test for patients with unexpected stupor or delirium. CASE REPORTS: The two case reports show the clinical range from acute decompensation with acute cerebral herniation followed by fatal outcome to recovery under emergency therapy without substantial neurological deficits. THERAPY: Emergency treatment consists of symptomatic securing of vital parameters and an immediate reduction in the ammonia level using high calorie, protein-free nutrition to avoid catabolism together with administration of arginine, benzoate or phenyl butyrate. In cases of coma with severe cerebral edema and the threat of a herniation reaction or excessive ammonia levels, emergency hemodialysis must be immediately carried out.
CONCLUSIONS: In the clinical routine it is extremely important to consider a metabolic defect at an early phase and among others to determine the ammonia level so that the appropriate treatment can be instigated in time.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468698     DOI: 10.1007/s00101-009-1540-1

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  24 in total

Review 1.  Unmasked adult-onset urea cycle disorders in the critical care setting.

Authors:  Marshall L Summar; Frederick Barr; Sheila Dawling; Wendy Smith; Brendan Lee; Rani H Singh; William J Rhead; Lisa Sniderman King; Brian W Christman
Journal:  Crit Care Clin       Date:  2005-10       Impact factor: 3.598

Review 2.  European Resuscitation Council guidelines for resuscitation 2005. Section 4. Adult advanced life support.

Authors:  Jerry P Nolan; Charles D Deakin; Jasmeet Soar; Bernd W Böttiger; Gary Smith
Journal:  Resuscitation       Date:  2005-12       Impact factor: 5.262

3.  Neurological outcome of patients with ornithine carbamoyltransferase deficiency.

Authors:  P Nicolaides; D Liebsch; N Dale; J Leonard; R Surtees
Journal:  Arch Dis Child       Date:  2002-01       Impact factor: 3.791

4.  Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations.

Authors:  Annick Legras; François Labarthe; François Maillot; Marie-Ange Garrigue; Achille Kouatchet; Hélène Ogier de Baulny
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

5.  Long-term treatment of girls with ornithine transcarbamylase deficiency.

Authors:  N E Maestri; S W Brusilow; D B Clissold; S S Bassett
Journal:  N Engl J Med       Date:  1996-09-19       Impact factor: 91.245

6.  Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl.

Authors:  Işik Görker; Umran Tüzün
Journal:  J Psychiatry Neurosci       Date:  2005-03       Impact factor: 6.186

7.  The molecular basis of ornithine transcarbamylase deficiency.

Authors:  M Tuchman; B A McCullough; M Yudkoff
Journal:  Eur J Pediatr       Date:  2000-12       Impact factor: 3.183

8.  Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.

Authors:  M L Batshaw; Y Roan; A L Jung; L A Rosenberg; S W Brusilow
Journal:  N Engl J Med       Date:  1980-02-28       Impact factor: 91.245

9.  Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.

Authors:  Gregory M Enns; Susan A Berry; Gerard T Berry; William J Rhead; Saul W Brusilow; Ada Hamosh
Journal:  N Engl J Med       Date:  2007-05-31       Impact factor: 91.245

10.  Intracranial pressure, cerebral blood flow, and cerebrospinal fluid formation during hyperammonemia in cat.

Authors:  A Chodobski; J Szmydynger-Chodobska; A Urbańska; E Szczepańska-Sadowska
Journal:  J Neurosurg       Date:  1986-07       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.